nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients
|
Chanprapaph, K |
|
2017 |
26 |
12 |
p. 1278-1284 |
artikel |
2 |
Cessation of oral anticoagulants in antiphospholipid syndrome
|
Comarmond, C |
|
2017 |
26 |
12 |
p. 1291-1296 |
artikel |
3 |
Cessation of oral anticoagulants in antiphospholipid syndrome
|
Espinosa, G |
|
2017 |
26 |
12 |
p. 1347-1348 |
artikel |
4 |
Circulating prolactin level in systemic lupus erythematosus and its correlation with disease activity: a meta-analysis
|
Song, G G |
|
2017 |
26 |
12 |
p. 1260-1268 |
artikel |
5 |
Clinico-pathological features of repeat renal biopsies in patients with lupus nephritis at Groote Schuur Hospital, Cape Town
|
Kajawo, S |
|
2017 |
26 |
12 |
p. 1339-1346 |
artikel |
6 |
Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
|
Resseguier, A S |
|
2017 |
26 |
12 |
p. 1297-1303 |
artikel |
7 |
Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis
|
Lythgoe, H |
|
2017 |
26 |
12 |
p. 1285-1290 |
artikel |
8 |
Genetic variants in FH are associated with renal histopathologic subtypes of lupus nephritis: a large cohort study from China
|
Tan, M |
|
2017 |
26 |
12 |
p. 1309-1317 |
artikel |
9 |
Hydroxychloroquine-induced hyperpigmentation in systemic diseases: prevalence, clinical features and risk factors: a cross-sectional study of 41 cases
|
Bahloul, E |
|
2017 |
26 |
12 |
p. 1304-1308 |
artikel |
10 |
Immunomodulation in systemic lupus erythematosus: induction of M2 population in monocyte-derived macrophages by pioglitazone
|
Mohammadi, S |
|
2017 |
26 |
12 |
p. 1318-1327 |
artikel |
11 |
Independent validation of the adjusted GAPSS: Role of thrombotic risk assessment in the real-life setting
|
Fernandez Mosteirin, N |
|
2017 |
26 |
12 |
p. 1328-1332 |
artikel |
12 |
Lower kidney allograft survival in African–Americans compared to Hispanic–Americans with lupus
|
Gonzalez-Suarez, M L |
|
2017 |
26 |
12 |
p. 1269-1277 |
artikel |
13 |
Neuropsychiatric symptoms in systemic lupus erythematosus: impact on quality of life
|
Monahan, R C |
|
2017 |
26 |
12 |
p. 1252-1259 |
artikel |
14 |
Successful treatment of refractory systemic lupus erythematosus using proteasome inhibitor bortezomib followed by belimumab: description of two cases
|
Sjöwall, C |
|
2017 |
26 |
12 |
p. 1333-1338 |
artikel |
15 |
Ultraviolet-A1 irradiation therapy for systemic lupus erythematosus
|
McGrath, H |
|
2017 |
26 |
12 |
p. 1239-1251 |
artikel |